While shares have posted break-even returns so far in 2024, Pfizer stock has cratered by more than 30% over the ...

We recently published a list of 10 Best Biotech Stocks To Buy Under $20. In this article, we are going to take a look at ...

Looking at a slightly longer term, the performance of PFE stock with respect to the index has been quite volatile in recent ...

Two of the nation's biggest banks will kick off earnings season for lenders Friday when JPMorgan Chase and Wells Fargo report results. It was an unusual quarter for the U.S. financial system, marked ...

While Pfizer has made a number of acquisitions, its biggest bet is on Seagen. Pfizer wants this to be a transformative acquisition, and it projects Seagen to contribute $10 billion in sales by 2030.

The smart money seems to be calling a bottom for the healthcare sector. That could mean it’s time for investors to start taking another look at the industry’s more beleaguered stocks. Since the start ...

Wall Street jumped by the most in three weeks as a rally in technology stocks pushed the S&P 500 to within one-fifth of a percentage point from a record high close.

--Pfizer's Chief Executive Albert Bourla plans to meet Starboard Value next week with at least one other director after the activist investor acquired a $1 billion stake in the healthcare company, the ...

The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.

Pfizer CEO Albert Bourla plans to meet activist investor Starboard Value, the Financial Times reported on Tuesday, citing ...

The Roundhill Magnificent Seven ETF — which holds Big Tech stocks including Nvidia, Apple Inc., Microsoft Corp, Alphabet Inc.

Second annual award supports innovative projects focused on improving dermatological care for underrepresented populations ...